loadpatents
name:-0.051493167877197
name:-0.027514934539795
name:-0.038641929626465
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY Patent Filings

NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY

Patent Applications and Registrations

Patent applications and USPTO patent grants for NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY.The latest application filed is for "antisense nucleic acids".

Company Profile
45.44.59
  • NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - Tokyo JP
  • NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - Kodaira-shi, Tokyo JP
  • NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - Kodaira N/A JP
  • National Center of Neurology and Psychiatry - JP JP
  • NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY -
  • NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - Kodaira-shi Tokyo JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nucleic Acid Delivery Complex
App 20220127606A1 -
2022-04-28
Antisense Nucleic Acids
App 20210147839 - ENYA; Yukiko ;   et al.
2021-05-20
Oligodendrocyte-specific Promoter, Mirna Specific To Plp1 Gene,vector Including Said Promoter And/or Mirna, And Pharmaceutical Composition Including Said Vector
App 20210087560 - Inoue; Ken ;   et al.
2021-03-25
Inducer of muscle differentiation
Grant 10,934,543 - Hohjoh , et al. March 2, 2
2021-03-02
Neonatal Hypoxic-ischemic Encephalopathy Severity Determining Method And Prognosis Predicting Method
App 20210041468 - ITO; Masayuki ;   et al.
2021-02-11
Antisense nucleic acids
Grant 10,870,676 - Watanabe , et al. December 22, 2
2020-12-22
Antisense nucleic acids
Grant 10,851,373 - Enya , et al. December 1, 2
2020-12-01
Antisense nucleic acids
Grant 10,781,448 - Watanabe , et al. Sept
2020-09-22
Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
Grant 10,782,290 - Yamamura , et al. Sept
2020-09-22
Stem Cells For Transplantation And Manufacturing Method Therefor
App 20200222506 - OKADA; TAKASHI ;   et al.
2020-07-16
System, Method, and Program for Predicting Diminished Attentiveness State, and Storage Medium on Which Program Is Stored
App 20200218935A1 -
2020-07-09
Method for determining application of therapy to multiple sclerosis (MS) patient
Grant 10,697,883 - Yamamura , et al.
2020-06-30
Biomarker For Diagnosing Depression And Use Of Biomarker
App 20200191768A1 -
2020-06-18
Antisense nucleic acids
Grant 10,683,322 - Watanabe , et al.
2020-06-16
Antisense nucleic acids
Grant 10,662,217 - Watanabe , et al.
2020-05-26
Method For Predicting And Evaluating Therapeutic Effect In Diseases Related To Il-6 And Neutrophils
App 20200148760A1 -
2020-05-14
Antisense Nucleic Acids
App 20200149040A1 -
2020-05-14
Antisense nucleic acids
Grant 10,647,741 - Watanabe , et al.
2020-05-12
Antisense Nucleic Acids
App 20200115411A1 -
2020-04-16
Agent For Improving Brain Function And Agent For Preventing Or Treating Cognitive Impairment
App 20200108040A1 -
2020-04-09
Antisense Nucleic Acids
App 20200109162A1 -
2020-04-09
Antisense Nucleic Acids
App 20200102343 - WATANABE; Naoki ;   et al.
2020-04-02
Prophylactic Agent, Onset-suppressing Agent Or Therapeutic Agent For Progressive Immune Demyelinating Diseases
App 20200071408 - OKI; Shinji ;   et al.
2020-03-05
Method For Detecting Mood Disorders
App 20200024663 - NAKAMURA; Seiji ;   et al.
2020-01-23
Mutant Of Adeno-associated Virus (aav) Capsid Protein
App 20200002384 - OKADA; Takashi ;   et al.
2020-01-02
Antisense nucleic acids
Grant 10,487,106 - Watanabe , et al. Nov
2019-11-26
Inducer Of Muscle Differentiation (as Amended)
App 20190330627 - HOHJOH; Hirohiko ;   et al.
2019-10-31
Antisense Nucleic Acids
App 20190315796 - WATANABE; Naoki ;   et al.
2019-10-17
Antisense nucleic acids
Grant 10,407,461 - Watanabe , et al. Sept
2019-09-10
Antisense nucleic acids
Grant 10,385,092 - Watanabe , et al. A
2019-08-20
Antisense Nucleic Acids
App 20190218244 - Watanabe; Naoki ;   et al.
2019-07-18
Antisense Nucleic Acids
App 20190211049 - WATANABE; Naoki ;   et al.
2019-07-11
Antisense Nucleic Acids
App 20190211050 - WATANABE; Naoki ;   et al.
2019-07-11
Antisense nucleic acids
Grant 10,329,319 - Watanabe , et al.
2019-06-25
Antisense Nucleic Acids
App 20190040387 - ENYA; Yukiko ;   et al.
2019-02-07
Biomarker For Diagnosing Depression And Use Of Said Biomarker
App 20180348195 - KATO; Takahiro ;   et al.
2018-12-06
Antisense nucleic acids
Grant 10,144,931 - Enya , et al. De
2018-12-04
Stem Cells For Transplantation And Manufacturing Method Therefor
App 20180333462 - OKADA; Takashi ;   et al.
2018-11-22
Stem Cells For Transplantation And Manufacturing Method Therefor
App 20180333463 - OKADA; Takashi ;   et al.
2018-11-22
Antisense Nucleic Acids
App 20180265866 - ENYA; Yukiko ;   et al.
2018-09-20
Autoimmune Disease Diagnosis Method, Autoimmune Disease Diagnosis Biomarker, And Autoimmune Disease Preventing Or Treating Agent
App 20180245138 - YAMAMURA; Takashi ;   et al.
2018-08-30
Therapeutic Agent For Mental Illness Comprising Il-6 Inhibitor As Active Ingredient
App 20180186887 - KUNUGI; Hiroshi ;   et al.
2018-07-05
Antisense Nucleic Acids
App 20180179538 - Wakayama; Tatsushi ;   et al.
2018-06-28
Agent For Improving Brain Function And Agent For Preventing Or Treating Cognitive Impairment
App 20180169052 - KUNUGI; Hiroshi ;   et al.
2018-06-21
Antisense nucleic acids
Grant 9,988,629 - Wakayama , et al. June 5, 2
2018-06-05
Method For Determining Application Of Novel Therapy To Multiple Sclerosis (ms) Patient
App 20180149573 - Yamamura; Takashi ;   et al.
2018-05-31
Agent Containing Imidazole Dipeptide
App 20180140655 - Hisatsune; Tatsuhiro ;   et al.
2018-05-24
Antisense Nucleic Acids
App 20180142245 - WATANABE; Naoki ;   et al.
2018-05-24
Biomarker For Mental Disease
App 20180100177 - KUNUGI; Hiroshi ;   et al.
2018-04-12
Morphinan Derivative
App 20180057493 - NAGASE; Hiroshi ;   et al.
2018-03-01
Antisense Nucleic Acids
App 20180044675 - WATANABE; Naoki ;   et al.
2018-02-15
Antisense nucleic acids
Grant 9,890,381 - Watanabe , et al. February 13, 2
2018-02-13
Cognitive function testing system, cognitive function estimation system, cognitive function testing method, and cognitive function estimation method
Grant 9,848,811 - Yasumura , et al. December 26, 2
2017-12-26
Antisense nucleic acids
Grant 9,840,706 - Watanabe , et al. December 12, 2
2017-12-12
Muscular Dystrophy Therapeutic Agent Containing Pluripotent Stem Cells Derived From Dental Pulp
App 20170327791 - OKADA; Takashi ;   et al.
2017-11-16
Antisense Nucleic Acids
App 20170320903 - WATANABE; Naoki ;   et al.
2017-11-09
Antisense Nucleic Acids
App 20170204410 - WATANABE; Naoki ;   et al.
2017-07-20
Antisense nucleic acids
Grant 9,708,361 - Watanabe , et al. July 18, 2
2017-07-18
Drug Delivery Particle and Method for Producing the Same
App 20170172936 - Okada; Takashi ;   et al.
2017-06-22
Agent Containing Imidazole Dipeptide
App 20170165314 - Hisatsune; Tatsuhiro ;   et al.
2017-06-15
GM-CSF-PRODUCING T-CELL CONTROL AGENT AND Th1/Th2 IMMUNE BALANCE REGULATOR
App 20170151270 - YAMAMURA; Takashi ;   et al.
2017-06-01
Drug delivery particle and method for producing the same
Grant 9,610,354 - Okada , et al. April 4, 2
2017-04-04
Antisense Nucleic Acids
App 20170067048 - WAKAYAMA; Tatsushi ;   et al.
2017-03-09
Antisense Nucleic Acids
App 20170067052 - WATANABE; Naoki ;   et al.
2017-03-09
Antisense nucleic acids
Grant 9,512,424 - Watanabe , et al. December 6, 2
2016-12-06
Method For Predicting Post-therapy Prognosis Of Relapsing-remitting Multiple Sclerosis (rrms) Patient, And Method For Determining Applicability Of Novel Therapy
App 20160139117 - Yamamura; Takashi ;   et al.
2016-05-19
Stem Cells For Transplantation And Manufacturing Method Therefor
App 20160089421 - OKADA; Takashi ;   et al.
2016-03-31
Method For Alleviating Fear Memory
App 20150272918 - SEKIGUCHI; Masayuki ;   et al.
2015-10-01
Method for alleviating fear memory
Grant 9,107,891 - Sekiguchi , et al. August 18, 2
2015-08-18
Marker For Detecting Myogenic Disease And Detection Method Using The Same
App 20150211069 - Hashido; Kazuo ;   et al.
2015-07-30
Antisense nucleic acids
Grant 9,079,934 - Watanabe , et al. July 14, 2
2015-07-14
Antisense Nucleic Acids
App 20150166995 - WATANABE; Naoki ;   et al.
2015-06-18
Cognitive Function Testing System, Cognitive Function Estimation System, Cognitive Function Testing Method, And Cognitive Function Estimation Method
App 20150119731 - Yasumura; Akira ;   et al.
2015-04-30
Antisense Nucleic Acids
App 20140343266 - Watanabe; Naoki ;   et al.
2014-11-20
Method For Alleviating Fear Memory
App 20140121276 - Sekiguchi; Masayuki ;   et al.
2014-05-01
Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
Grant 8,658,390 - Urade , et al. February 25, 2
2014-02-25
Drug Delivery Particle and Method for Producing the Same
App 20140044794 - Okada; Takashi ;   et al.
2014-02-13
Antisense Nucleic Acids
App 20130211062 - Watanabe; Naoki ;   et al.
2013-08-15
Agent For Suppressing Expression Of Dominant Allele
App 20130090373 - Hohjoh; Hirohiko ;   et al.
2013-04-11
Molecular Marker For Evaluating Pathological Conditions And Treatment Of Muscular Dystrophy
App 20120329046 - Takeda; Shin'ichi ;   et al.
2012-12-27
Method For Generating Homoplasmic Cells From Heteroplasmic Cells
App 20120040464 - Ling; Feng ;   et al.
2012-02-16
Method For Detecting Muscle Degenerative Diseases, And Method For Determining Therapeutic Efficacy On The Diseases
App 20110318764A1 -
2011-12-29
Method for assisting in diagnosis of cerebral diseases and apparatus thereof
App 20090252391 - Matsuda; Hiroshi ;   et al.
2009-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed